Shaobing Gao

127 Dongming Road
Zhengzhou, 450008, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Identification of Copy Number Alterations From Shallow Whole-Genome Sequencing in Multiple Myeloma.

Identification of Copy Number Alterations From Shallow Whole-Genome Sequencing in Multiple Myeloma.

Journal: Hematological oncology
Published: October 16, 2024

Key regulators of sensitivity to immunomodulatory drugs in cancer treatment.

Key regulators of sensitivity to immunomodulatory drugs in cancer treatment.

Journal: Biomarker research
Published: March 15, 2021

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment.

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment.

Journal: Science advances
Published: December 21, 2020

Recent advances in the molecular mechanism of thalidomide teratogenicity.

Recent advances in the molecular mechanism of thalidomide teratogenicity.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 06, 2020

Novel immunomodulatory drugs and neo-substrates.

Novel immunomodulatory drugs and neo-substrates.

Journal: Biomarker research
Published: August 28, 2019

Restriction of hepatitis B virus replication by c-Abl-induced proteasomal degradation of the viral polymerase.

Restriction of hepatitis B virus replication by c-Abl-induced proteasomal degradation of the viral polymerase.

Journal: Science advances
Published: July 16, 2018

CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory.

CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory.

Journal: PLoS genetics
Published: August 07, 2017

Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase.

Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase.

Journal: The Journal of biological chemistry
Published: October 03, 2016
Showing 1-8 of 8

Last Updated: 09/26/2026